Prolonged intravenous ritodrine therapy: a comparison between multiple and singleton pregnancies.
To compare multiple and singleton pregnancies in the treatment of threatened preterm delivery with prolonged intravenous ritodrine, 32 women with multiple pregnancy (26 twins, 6 triplets, 70 fetuses, 30.3 +/- 3.5 weeks) and 51 women with singleton pregnancy (31.3 +/- 2.6 weeks) admitted for threatened preterm delivery without rupture of the membranes were the subjects of a retrospective study of obstetric data, perinatal outcome and maternal adverse effects. Significance was assessed by chi 2 test and Student's t test. Multiple pregnancies were associated with a marked increase in the duration of tocolysis (17.2 +/- 17.3 vs. 7.6 +/- 8.1 days, P < 0.01), incidence of delivery before 37 weeks (87.5 vs. 35.3%, P < 0.01) and incidence of maternal cardiovascular complications (34.4 vs. 4.0%, P < 0.01), including three cases of pulmonary edema. The incidences of delivery before 32 weeks (12.5 vs. 7.8%) and of neonatal death (2.9 vs. 0%) were not significantly different in the two groups. Multiple pregnancies dramatically increased the incidence of maternal adverse effects of prolonged intravenous ritodrine therapy. Neonatal benefit is questionable and was difficult to establish since it was not a randomized study.
Gabriel
R
R
Clinique Obstétricale et Gynécologique, Université de Reims, Hôpital Maison Blanche, France.
Harika
G
G
Saniez
D
D
Durot
S
S
Quereux
C
C
Wahl
P
P
D000328:Adult; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007752:Obstetric Labor, Premature / Q000188:drug therapy*; D011247:Pregnancy; D011256:Pregnancy Outcome; D011272:Pregnancy, Multiple; D012189:Retrospective Studies; D012312:Ritodrine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D015145:Tocolysis; D014310:Triplets; D014427:Twins
D012312:Ritodrine